[Ngo-admin] External consultant for Drug utilization study in Vietnam

[Giang Ngan Ha]

Dear Ms. Phuong,

Please send the attached file for the vacancy announcement. The below 
includes tables which we can not post the same format on our website.

Regards,

Bui Thi Kim Ngan
Administrator
VUFO - NGO Resource Centre

On 05/03/2012 09:24 AM, thuy nguyen phuong wrote:
>
> *Title: *Technical*Expert*/Consultant for building up protocol and 
> technical assistance in medicine utilization study
>
> *Reports to: *The DI&ADR Center and Project Coordinator
>
> *Duty Station: *Several weeks in Vietnam and**home based
>
> *Expected Places of Travel (if applicable):*Hanoi and Ho Chi Minh City 
> and other cities in Vietnam if required
>
> *Duration of Assignment: *From April *– *December 2012
>
> */P/**rovision of Support Services:*
>
> 	
>
> /Office space/:
>
> 	
>
> Yes (if consultants come to Vietnam)
>
> /Secretarial Services/Technical support group:/
>
> 	
>
> Yes (related to Vietnamese technical aspects)
>
> Indicate here who will be responsible for providing the support services:
>
> *I.**Background information*
>
>
> General information
>
> The Health System Strengthening Project funded by the Global Fund will 
> be implemented for 5 years (2012-2016). The first phase will be 
> implemented during 2012- 2013. The objective of the project is to 
> support strengthening the capacity of the health system to improve the 
> outcomes of HIV/AIDS, TB and Malaria prevention, the mother and 
> children’s healthcare. The project is managed by the MOH. The project 
> covers 15 provinces: Ha Nam, Cao Bang, Lang Son, Quang Ninh, Bac 
> Giang, Thai Nguyen, Lai Chau, Dien Bien, Khanh Hoa, Ninh Thuan, Binh 
> Phuoc, Tay Ninh, Dong Thap, An Giang and Soc Trang; Hanoi University 
> of Pharmacy and Drugs Unit at sentinel provinces/cities; National 
> Institute of Drugs Quality Control (NIDQC), Ho Chi Minh city Institute 
> of Drugs Quality Control and 61 Centers at provincial level. Main 
> project activities include:
>
> Major SR-HUP activities:
>
> -Act1. Provide technical support, equipments and database system for 
> National, Regional
>
> -&ADR Centers, PV technical units in 3 PHPs and sentinel hospitals in 
> PV system.
>
> -Act 2. Provide training courses on Pharmacovigilance for health staff 
> with several levels
>
> training.
>
> -Act 3. Develop a national guideline for drug safety, Good 
> Pharmacovigilance Practice, some protocols, SOPs and reporting forms… 
> for drug safety and drug information activities in Pharmacovigilance 
> system.
>
> -Act4. Conduct Pharmacovigilance active surveillance in TB and Malaria 
> programs.
>
> -Act5. Develop and perform different tools of feedback (individual 
> feedback, quarterly feedback reports, alerts, quarterly bulletins, 
> performance review on Pharmacovigilance activities in PHPs, annual 
> scientific review and forum of Pharmacovigilance…).
>
> -Act 6. Conduct researches/studies on specific areas in Pharmacovigilance.
>
> -Act 7. Implement information and education campaign on Pharmacovigilance.
>
> -Act 8. Conducted a national advocacy program on the importance and 
> use of pharmacovigilance
>
> The National Drug Information – Adverse Drug Reaction Centre of Viet 
> Nam (herein referred to as the National Centre) has been assigned to 
> implement these activities under Health System Strengthening Project – 
> Intervention 2.1 – Establishing a national pharmacovigilance 
> system.One of the specific activities under this project is a series 
> of hands-on training for healthcare professionals in the national 
> pharmacovigilance system.
>
> As part of the risk management and monitoring system, the National 
> Centre will conduct a baseline study on medicines utilization. The 
> baseline study will contribute to continuing evaluation of medicine 
> use and to help the health system manage risks, prevent adverse events 
> and improve rational use of medicines among healthcare professionals.
>
> *II.**Objectives of Assignment*
>
>
> The objectives of this assignment are:
>
> a)Develop the protocol and/or tool for the medicines utilization study 
> at the facility level;
>
> b)Develop the corresponding manuals and data collection forms for the 
> study
>
> c)Provide a framework for data input and analysis
>
> d)Provide initial training in the use of the protocol
>
> e)Provide assistance in the field testing of the protocol
>
> f)Supervision of the study including data collection, data entry, 
> analysis and writing report
>
> *III.**Scope of work*
>
>
> The Technical Expert/ Consultant shall work in consultation with the 
> Director/Vice Director of The National DI&ADR Center and the technical 
> working group, and under close supervision of the project Coordinator.
>
> Specifically the scope of work shall include:
>
> 1. Develop a detailed protocol of a medicine utilization study which 
> includes at least following sections:
>
>
>   a.Background:
>
>
>   a.1. Datareview (a summary of findings from similar studies that
>   potentially have clinical significance and from clinical researches
>   that are relevant to the study.
>
>
>   a.2. Literature: Reference any literature and other data that are
>   relevant to the study and that provide background for the study.
>
> b.Study design: type of the study
>
> c.Data collection: type of data, criteria of data,sample size 
> calculation,, form of questionnaires to collect data, SOP for data 
> collection, toolkit of data quality assurance
>
> d.Methods: study parameters/endpoints (main and secondary endpoints)
>
> e.Study procedures
>
> f.Statistic analysis: statistic methods, statistic software
>
> g.Ethical and administrative aspects
>
> 2. Develop the study manuals/user guides
>
> 3. Provide training for the interviewers and data collectors and assessors
>
> 4. Provide technical assistance and guidance in the filed testing of 
> the assessment tools
>
> 5. Develop/provide a framework for data input and analysis
>
> 6. Provide technical assistance during study implementation, data 
> collection and
>
> 7. Provide technical assistance in data entry, data analysis and 
> writing report
>
> *IV.**Expected Results / Deliverables / Final Products Expected*
>
>
> The consultant is expected to complete all work identified above 
> within eight (8) months from the date of commencement, inclusive of 
> the conduct of the study.
>
> The expected deliverables include:
>
> 1.Survey protocols
>
> 2.Survey forms and data collection toolkits
>
> 3.User manuals and standard operating procedures for quality assurance
>
> 4.Training materials for interviewers and data assessors
>
> 5.Framework for data input and analysis
>
> 6.Documents of supervision
>
> The consultant will submit one electronic copy in MS Word format for 
> each of the deliverables.
>
> *VI.**Remuneration and mode of payment*
>
> Review/approval time required to review/approve the outputs prior to 
> authorizing payments.
>
> The consultant will submit one electronic copy in MS Word format with 
> following deliverables.
>
> *Deliverables*
>
> 	
>
> *Due*
>
> 	
>
> *Percentage of total*
>
> *professional fee**
>
> Upon signing of the contract
>
> 	
>
> ASAP
>
> 	
>
> 25%
>
> The final version of protocol, toolkit,user guide manuals, data 
> collection forms and framework for database
>
> 	
>
> 30 May 2012
>
> 	
>
> 25%
>
> Initial training for users of the toolkit and filed testing
>
> 	
>
> 25 June 2012
>
> 	
>
> 10%
>
> Technical report for study supervision (data collection, data entry)
>
> 	
>
> 30 September 2012
>
> 	
>
> 25%
>
> Technical report for data analysis and writing report
>
> 	
>
> 30 November 2012
>
> 	
>
> 15%
>
> ·
>
> *VII.**General requirements*
>
> Demonstrated solid experience on designing and developing study 
> protocol in medicine utilization
>
> ·Excellent writing, communication and presentation skills in English
>
> ·Proven track record of having worked with Pharmacovigilance (PV) 
> initiatives is an advantage
>
> ·Self-motivated, ability to work independently
>
> ·Excellent communication and interpersonal skills, team oriented work 
> style, interest and experience of working in high pressure environment.
>
> Education:
>
> Doctor of Medicine or Masters Degree or PhD holder in PV, public 
> health, epidemiology and drug safety and other relevant fields,
>
> Other selection criteria:
>
> 1. Minimum 7 year experience in medicine utilization studies and 
> health research or other relevant fields
>
> 2. Publications in international/local journals.
>
> 3. Familiarity of developing country context and experience working in 
> international organizations and development partners will be an asset.
>
> * *Remuneration:*competitive (including transportation cost, living 
> allowances, individual income tax... Basic living allowances will be 
> based on UN post adjustment cost-norms)
>
>
> *Application:*Professional CV including an individual picture, Express 
> of interest letter, Draft technical proposal of the assignment
>
> *Deadline:*15/05/2012
>
> *Contact information: *Applicant sends application (by post, fax or 
> email) to:
>
> Address: Global Fund Project – HSS - Intervention 2.1. 
> Pharmacovigilance – The National Drug information and Adverse drug 
> reactions monitoring (DI&ADR center) – 13 -15 Le Thanh Tong, Ha Noi, 
> Vietnam
>
> Phone: +84 439335618, Fax: +84 439335642 ; Email: pv.gf10 at gmail.com 
> <mailto:pv.gf10 at gmail.com>
>
> Contact person: Nguyen Phuong Thuy (phone: + 84 949919993); 
> Email:nguyenphuongthuy93 at gmail.com <mailto:nguyenphuongthuy93 at gmail.com>
>
>
>
>
> -- 
> Regards!
> Nguyễn Phương Thúy
> Vietnamese Drug Information & Adverse Drug Reactions monitoring Centre
> Hanoi University of Pharmacy
> 3th floor GMP Building
> 13-15 Le Thanh Tong, Hoan Kiem District, Hanoi, Vietnam
> Tel +84 43 933 5618
> Fax +84 43 933 5642
> Mobile +84 949 919 993
>
>
> Sent from the Administrators Working Group Mailing List.
> If you reply, please do not CC everyone on the list. Rather, send a separate message to the individual you are replying to.
> Address to post a new message: Ngo-admin at ngocentre.org.vn
> Avoid sending attachments, but if you must send them keep them small - 500 kilobyte maximum for each email.
>